Michele Danilo Pierri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michele Danilo Pierri has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Mauro Borioni
3 shared publicationsGian Piero Piccoli
2 shared publications- Alessandro D'Alfonso
Department of Cardiac Surgery, Ospedali Riuniti di Ancona, Ancona, Italy
1 shared publication - Andrea Quarti
Department of Cardiovascular Medicine, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy
1 shared publication Benedetto Del Forno
1 shared publicationCarlo Sorbara
1 shared publication
Latest Publications
- 8 October 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (5) , 1696-1702
COVID 19— Perspective of an Italian Center
Italy has been hard hit by severe acute respiratory syndrome coronavirus 2 infection with more than 240,000 cases and 35,000 deaths. During the acute phase of the pandemic, the Italian government decided on the lockdown which lasted about 2 months. During this period, all surgical activities were limited to nondeferable procedures only. The sudden closure posed problems with the management of the heart surgery waiting which at that time included 135 patients. Among these were selected cases with the worst clinical characteristics that were progressively operated on. Compared with a similar period in 2019, the cardiac surgery activity of the "Lancisi Cardiovascular Center" in Ancona has been reduced by 65%. With pandemic mitigation, heart surgery activity has gradually resumed but many open questions remain. Above all, there is the problem of living with a low but persistent level of presence of the virus with the need to organize the activity to ensure patients and staff safety and an optimal level of performance.
- 8 October 2020
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (5) , 1696-1702
COVID 19— Perspective of an Italian Center
Italy has been hard hit by severe acute respiratory syndrome coronavirus 2 infection with more than 240,000 cases and 35,000 deaths. During the acute phase of the pandemic, the Italian government decided on the lockdown which lasted about 2 months. During this period, all surgical activities were limited to nondeferable procedures only. The sudden closure posed problems with the management of the heart surgery waiting which at that time included 135 patients. Among these were selected cases with the worst clinical characteristics that were progressively operated on. Compared with a similar period in 2019, the cardiac surgery activity of the "Lancisi Cardiovascular Center" in Ancona has been reduced by 65%. With pandemic mitigation, heart surgery activity has gradually resumed but many open questions remain. Above all, there is the problem of living with a low but persistent level of presence of the virus with the need to organize the activity to ensure patients and staff safety and an optimal level of performance.
- 1 April 2004
- Vol. 5 (4) , 265-70
Aortic valve-sparing surgery for aortic root aneurysm.
Replacement of the aortic valve and ascending aorta with a composite graft is the most common surgical treatment for aortic root aneurysms with or without aortic regurgitation (AR). In the early 90's reconstructive procedures of the aortic root have been described with encouraging results. This paper presents our experience with this technique. Between January 2001 and May 2003, 28 patients (25 males, 3 females, mean age 60 years) with aortic root aneurysm were treated with reimplantation of the aortic valve. Twenty-two patients had AR > 2+, 5 had Marfan syndrome, 5 had an aortic arch aneurysm, 4 had type A aortic dissection, 2 patients had associated coronary artery disease, and one had mitral valve insufficiency. The only contraindication was primitive disease of the aortic leaflets. There was one perioperative death (type A aortic dissection) and 1 patient was discharged with mild to moderate AR requiring aortic valve replacement. The cardiopulmonary bypass and aortic cross-clamping times were 230 and 184 min respectively. No neurological events were recorded. During follow-up (mean 16.7 months, range 3-32 months) 1 patient died and one had mild AR. Freedom from reoperation and from AR at 24 months was 94 and 89% respectively. At multivariate analyses we did not find any correlation between Marfan syndrome, type A aortic dissection, grade of preoperative AR, and recurrence of AR. In our experience, valve-sparing surgery was feasible with a low mortality and morbidity and with good early results. It should be applied to all patients requiring aortic root surgery for aortic root aneurysm, a diseased aortic valve being the only contraindication.
- 1 April 2004
- Vol. 5 (4) , 265-70
Aortic valve-sparing surgery for aortic root aneurysm.
Replacement of the aortic valve and ascending aorta with a composite graft is the most common surgical treatment for aortic root aneurysms with or without aortic regurgitation (AR). In the early 90's reconstructive procedures of the aortic root have been described with encouraging results. This paper presents our experience with this technique. Between January 2001 and May 2003, 28 patients (25 males, 3 females, mean age 60 years) with aortic root aneurysm were treated with reimplantation of the aortic valve. Twenty-two patients had AR > 2+, 5 had Marfan syndrome, 5 had an aortic arch aneurysm, 4 had type A aortic dissection, 2 patients had associated coronary artery disease, and one had mitral valve insufficiency. The only contraindication was primitive disease of the aortic leaflets. There was one perioperative death (type A aortic dissection) and 1 patient was discharged with mild to moderate AR requiring aortic valve replacement. The cardiopulmonary bypass and aortic cross-clamping times were 230 and 184 min respectively. No neurological events were recorded. During follow-up (mean 16.7 months, range 3-32 months) 1 patient died and one had mild AR. Freedom from reoperation and from AR at 24 months was 94 and 89% respectively. At multivariate analyses we did not find any correlation between Marfan syndrome, type A aortic dissection, grade of preoperative AR, and recurrence of AR. In our experience, valve-sparing surgery was feasible with a low mortality and morbidity and with good early results. It should be applied to all patients requiring aortic root surgery for aortic root aneurysm, a diseased aortic valve being the only contraindication.
- 1 February 2004
- Vol. 5 (2) , 137-41
[Mortality risk estimation in cardiac surgery].
The aim of this study was to compare the ability of three risk models to predict operative mortality after cardiac surgery. Risk factors of 3111 patients (73% male, mean age 65.2 +/- 10.7 years) were derived from our institutional database at the Cardiac Surgery Department of the G.M. Lancisi Hospital, Ancona, Italy. The predicted mortality was derived from the Society of Thoracic Surgeons risk score (STS), the EuroSCORE (ES) and the Northern New England Cardiovascular Disease Study Group score (NE). The observed mortality in the myocardial revascularization population (1995 patients) was 2.2% (43 patients). The mean predicted mortality by STS, ES and NE was 1.9, 4.2 and 1.9%, respectively. The predictive ability of the models was measured by means of the ROC curve. Curves were respectively of 0.82, 0.77 and 0.78. All tested models proved e good accuracy level but ES showed a constant overestimation of mortality at all risk levels.
- 1 February 2004
- Vol. 5 (2) , 137-41
[Mortality risk estimation in cardiac surgery].
The aim of this study was to compare the ability of three risk models to predict operative mortality after cardiac surgery. Risk factors of 3111 patients (73% male, mean age 65.2 +/- 10.7 years) were derived from our institutional database at the Cardiac Surgery Department of the G.M. Lancisi Hospital, Ancona, Italy. The predicted mortality was derived from the Society of Thoracic Surgeons risk score (STS), the EuroSCORE (ES) and the Northern New England Cardiovascular Disease Study Group score (NE). The observed mortality in the myocardial revascularization population (1995 patients) was 2.2% (43 patients). The mean predicted mortality by STS, ES and NE was 1.9, 4.2 and 1.9%, respectively. The predictive ability of the models was measured by means of the ROC curve. Curves were respectively of 0.82, 0.77 and 0.78. All tested models proved e good accuracy level but ES showed a constant overestimation of mortality at all risk levels.